Cost-effectiveness of cancer drugs: Comparative analysis of the United States and England

England's National Institute for Health and Care Excellence (NICE) and the US’ Institute for Clinical and Economic Review (ICER) both conduct cost-effectiveness evaluations for new cancer drugs to help payers make drug coverage decisions. However, NICE and ICER assessments have been noted to re...

Full description

Saved in:
Bibliographic Details
Published in:EClinicalMedicine 2020-12, Vol.29-30, p.100625-100625, Article 100625
Main Authors: Cherla, Avi, Renwick, Matthew, Jha, Ashish, Mossialos, Elias
Format: Article
Language:English
Subjects:
Cancer drugs
Cost-effectiveness
Institute for Clinical and Economic Review
Internal Medicine
National Institute for Health and Care Excellence
Research Paper
United Kingdom
United States
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!